XML 44 R5.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED SERIES EQUITY & STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Initial Public Offering
Common Stock
Common Stock
Initial Public Offering
Preferred Stock
Series A Convertible Preferred Stock
Preferred Stock
Series B Convertible Preferred Stock
Additional Paid-in-Capital
Additional Paid-in-Capital
Initial Public Offering
Retained Earnings (Accumulated Deficit)
Accumulated Other Comprehensive Income
Treasury Stock
Temporary equity, beginning balance, shares at Dec. 31, 2019         13,812,500            
Temporary equity, beginning balance at Dec. 31, 2019         $ 4,250            
Beginning balance, shares at Dec. 31, 2019     42,066,700                
Beginning balance at Dec. 31, 2019 $ 22,998   $ 421       $ 16,723   $ 9,732 $ 6 $ (3,884)
Net income (loss) 3,498               3,498    
Issuance of common stock, shares     319,015                
Issuance of common stock 1,842   $ 3       1,839        
Common stock repurchase, shares     (239,760)                
Common stock repurchase (1,538)   $ (2)       2       (1,538)
Issuance of series B convertible preferred stock, net of issuance costs, shares           6,608,700          
Issuance of series B convertible preferred stock, net of issuance costs           $ 36,030          
Series B convertible preferred stock dividend           $ 812          
Series B convertible preferred stock dividend, permanent equity (812)               (812)    
Options exercised, shares     4,592,585                
Options exercised 1,780   $ 45       1,735        
Foreign currency translation 817                 817  
Stock-based compensation 1,808           1,808        
Temporary equity, ending balance, shares at Dec. 31, 2020         13,812,500 6,608,700          
Temporary equity, ending balance at Dec. 31, 2020         $ 4,250 $ 36,842          
Ending balance, shares at Dec. 31, 2020     46,738,540                
Ending balance at Dec. 31, 2020 30,393   $ 467       22,107   12,418 823 (5,422)
Net income (loss) (13,693)               (13,693)    
Issuance of common stock, shares     151,515 8,984,375              
Issuance of common stock 1,001 $ 129,384 $ 1 $ 90     1,000 $ 129,294      
Common stock repurchase, shares     (85,049)                
Common stock repurchase (561)   $ (1)               (560)
Temporary equity, Conversion of Series A and Series B preferred stock to common stock, Shares         (13,812,500) (6,608,700)          
Temporary equity, Conversion of Series A and Series B preferred stock to common stock, Value         $ (4,250) $ (36,842)          
Conversion of Series A and Series B preferred stock to common stock, Shares     20,421,200                
Conversion of Series A and Series B preferred stock to common stock, Value 41,092   $ 204       40,076   812    
Options exercised, shares     236,706                
Options exercised 445   $ 2       443        
Foreign currency translation (815)                 (815)  
Stock-based compensation 4,948           4,948        
Ending balance, shares at Dec. 31, 2021     76,447,287                
Ending balance at Dec. 31, 2021 192,194   $ 763       197,868   (463) 8 (5,982)
Net income (loss) (67,326)               (67,326)    
Issuance of common stock, shares     0                
Offering costs associated with initial public offering (266)           (266)        
Options exercised, shares     1,284,333                
Options exercised 5,271   $ 13       5,258        
Foreign currency translation (41)                 (41)  
Employee stock purchase plan 731           731        
Employee stock purchase plan,Shares     38,968                
Stock-based compensation 10,365           10,365        
Ending balance, shares at Dec. 31, 2022     77,770,588                
Ending balance at Dec. 31, 2022 $ 140,928   $ 776       $ 213,956   $ (67,789) $ (33) $ (5,982)